BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Decrease in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant drop in short interest in October. As of October 15th, there was short interest totalling 1,100 shares, a drop of 42.1% from the September 30th total of 1,900 shares. Based on an average daily trading volume, of 3,900 shares, the days-to-cover ratio is presently 0.3 days.

BioSyent Price Performance

OTCMKTS BIOYF opened at $8.21 on Friday. The stock’s fifty day moving average is $7.92 and its two-hundred day moving average is $7.25. BioSyent has a fifty-two week low of $5.65 and a fifty-two week high of $8.90.

BioSyent Increases Dividend

The firm also recently declared a dividend, which was paid on Sunday, September 15th. Investors of record on Thursday, September 5th were issued a $0.0334 dividend. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a yield of 1.72%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.